Durability of long-term immunomodulating medications in the treatment of bullous pemphigoid

被引:1
作者
Awethe, Zaynah [1 ]
Viveiros, Matthew [1 ]
Kaffenberger, Jessica [1 ,2 ]
机构
[1] Ohio State Coll Med, Dept Dermatol, Columbus, OH USA
[2] Ohio State Coll Med, Dept Dermatol, 1328 Dublin Rd 100, Columbus, OH 43215 USA
关键词
autoimmune; blistering disease; bullous pemphigoid; drug survival; immunomodulating medications;
D O I
10.1016/j.jaad.2023.08.019
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:1287 / 1289
页数:3
相关论文
共 50 条
  • [41] A case of bullous pemphigoid developing under treatment with benralizumab for bronchial asthma
    Tanaka, Arisa
    Fujimura, Yu
    Fuke, Satoshi
    Izumi, Kentaro
    Ujiie, Hideyuki
    JOURNAL OF DERMATOLOGY, 2023, 50 (09) : 1199 - 1202
  • [42] Omalizumab as an alternative therapeutic tool in the treatment of bullous pemphigoid: A case report
    Vico-Alonso, Cristina
    Calleja-Algarra, Alba
    Aragon-Miguel, Raquel
    Sanchez-Velazquez, Alba
    Velasco-Tamariz, Virginia
    Luis Ortiz-Romero, Pablo
    Monsalvez-Honrubia, Veronica
    DERMATOLOGIC THERAPY, 2019, 32 (02)
  • [43] Clinical characterization, treatment, and outcome of nivolumab-induced bullous pemphigoid
    Liu, Miao
    Yuan, Maoye
    Sun, Wei
    Li, Zuojun
    Zhou, Xingchen
    Wang, Chunjiang
    INVESTIGATIONAL NEW DRUGS, 2023, 41 (06) : 802 - 807
  • [44] Double filtration plasmapheresis for the treatment of bullous pemphigoid: A three case report
    Kitabata, Y
    Sakurane, T
    Orita, H
    Kamimura, M
    Siizaki, K
    Narukawa, N
    Kaketaka, A
    Abe, T
    Kobata, H
    Akizawa, T
    THERAPEUTIC APHERESIS, 2001, 5 (06): : 484 - 490
  • [45] Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review
    Cao, Peng
    Xu, Wenjing
    Zhang, Litao
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [46] Methotrexate in the treatment of immune checkpoint blocker-induced bullous pemphigoid
    Shi, Connie R.
    Otto, Tracey S.
    Thompson, Leah L.
    Chang, Michael S.
    Reynolds, Kerry L.
    Chen, Steven T.
    EUROPEAN JOURNAL OF CANCER, 2021, 159 : 34 - 37
  • [47] Successful induction treatment of bullous pemphigoid using reslizumab: a case report
    Rhyou, Hyo-In
    Han, Song-Hee
    Nam, Young-Hee
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2021, 17 (01)
  • [48] Advancing Treatment in Bullous Pemphigoid: A Comprehensive Review of Novel Therapeutic Targets and Approaches
    Hsuan-Chi Chen
    Chuang-Wei Wang
    Wu Han Toh
    Hua-En Lee
    Wen-Hung Chung
    Chun-Bing Chen
    Clinical Reviews in Allergy & Immunology, 2023, 65 : 331 - 353
  • [49] Advancing Treatment in Bullous Pemphigoid: A Comprehensive Review of Novel Therapeutic Targets and Approaches
    Chen, Hsuan-Chi
    Wang, Chuang-Wei
    Toh, Wu Han
    Lee, Hua-En
    Chung, Wen-Hung
    Chen, Chun-Bing
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2023, 65 (03) : 331 - 353
  • [50] Treatment and mortality rate of bullous pemphigoid in China: a hospital-based study
    Zhang, Li-Ming
    Wu, Jian
    Xiao, Ting
    Jin, Guang-Yu
    Li, Jiu-Hong
    Geng, Long
    He, Chun-Di
    Gao, Xing-Hua
    Chen, Hong-Duo
    EUROPEAN JOURNAL OF DERMATOLOGY, 2013, 23 (01) : 94 - 98